NCT02117830View on ClinicalTrials.gov

A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Conditions
Healthy
Interventions
DRUG

Androxal 25 mg capsules

DRUG

Androxal 250 Capsules

DRUG

Placebo Capsules

DRUG

Moxifloxacin 400 mg

All Listed Sponsors
lead

Repros Therapeutics Inc.

INDUSTRY

NCT02117830 - A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects | Biotech Hunter | Biotech Hunter